These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8845495)

  • 21. [Therapeutic results in the treatment of small cell bronchial cancer: experience of the EORTC Lung Cancer Working Party (Belgium)].
    Sculier JP
    Bull Cancer; 1987; 74(5):565-8. PubMed ID: 2825858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent issue in the treatment of small-cell lung cancer].
    Ueoka H; Hiraki S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1665-70. PubMed ID: 9757190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of therapeutic trials of carboplatin in lung cancer.
    Bunn PA
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):27-33. PubMed ID: 2541506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of chemotherapy in the treatment of small cell lung cancer.
    Shepherd FA
    Chest Surg Clin N Am; 1997 Feb; 7(1):113-33. PubMed ID: 9001760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged administration of low-daily-dose etoposide: a superior dosing schedule?
    Greco FA; Hainsworth JD
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S101-4. PubMed ID: 8070017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy for small cell lung cancer.
    Sandler AB
    Semin Oncol; 2003 Feb; 30(1):9-25. PubMed ID: 12635086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party.
    Thatcher N; Girling DJ; Hopwood P; Sambrook RJ; Qian W; Stephens RJ
    J Clin Oncol; 2000 Jan; 18(2):395-404. PubMed ID: 10637255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.
    Lebeau B; Urban T; Bréchot JM; Paillotin D; Vincent J; Leclerc P; Meekel P; L'Her P; Lebas FX; Chastang C
    Cancer; 1999 Oct; 86(8):1480-7. PubMed ID: 10526276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intensive chemotherapy treatment of small-cell bronchial cancer].
    Sculier JP
    Rev Med Brux; 1990 Apr; 11(4):96-108. PubMed ID: 2160117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial.
    Souhami RL; Rudd R; Ruiz de Elvira MC; James L; Gower N; Harper PG; Tobias JS; Partridge MR; Davison AG; Trask C
    J Clin Oncol; 1994 Sep; 12(9):1806-13. PubMed ID: 8083704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.
    Girling DJ
    Lancet; 1996 Aug; 348(9027):563-6. PubMed ID: 8774567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of carboplatin in the treatment of lung cancer].
    Bréchot JM
    Bull Cancer; 2000 Aug; 87 Spec No():34-9. PubMed ID: 11082721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.
    Slevin ML; Clark PI; Joel SP; Malik S; Osborne RJ; Gregory WM; Lowe DG; Reznek RH; Wrigley PF
    J Clin Oncol; 1989 Sep; 7(9):1333-40. PubMed ID: 2549204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Hainsworth JD; Gray JR; Stroup SL; Kalman LA; Patten JE; Hopkins LG; Thomas M; Greco FA
    J Clin Oncol; 1997 Dec; 15(12):3464-70. PubMed ID: 9396399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of drug diversity in the treatment of small cell lung cancer.
    Murray N
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):38-42. PubMed ID: 11479896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose intensity in small cell lung cancer.
    Thatcher N; Lee SM; Woll PJ; Middleton M; Anderson H; Burt P; Stout R
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):12-8; discussion 45-8. PubMed ID: 9578057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-intensive therapy in small cell lung cancer.
    Elias A
    Chest; 1998 Jan; 113(1 Suppl):101S-106S. PubMed ID: 9438698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carboplatin/etoposide in small cell lung cancer.
    Bishop JF
    Oncology; 1992; 49 Suppl 1():11-7; discussion 17-8. PubMed ID: 1323807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group.
    Ignatiadis M; Mavroudis D; Veslemes M; Boukovinas J; Syrigos K; Agelidou M; Agelidou A; Gerogianni A; Pavlakou G; Tselepatiotis E; Nikolakopoulos J; Georgoulias V
    Clin Lung Cancer; 2005 Nov; 7(3):183-9. PubMed ID: 16354313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose chemotherapy in lung cancer.
    Souhami RL
    Chest; 1989 Jul; 96(1 Suppl):66S-68S. PubMed ID: 2544367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.